—
Tuberculosis (TB) remains a significant global health challenge, with millions of new cases diagnosed each year. The disease, caused by the bacterium Mycobacterium tuberculosis, primarily affects the lungs but can also impact other parts of the body. Early detection and appropriate treatment are crucial for managing TB effectively. In this context, the Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test represents a significant advancement in the diagnosis and management of drug-resistant forms of tuberculosis. Offered by DNA Labs UAE, this test is specifically designed to detect resistance to second-line antitubercular drugs, providing essential information for tailoring treatment plans.
The test costs 2460 AED and can be further explored by visiting DNA Labs UAE’s website.
The symptoms that might prompt a physician to recommend the Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test are varied. They often resemble those of standard tuberculosis but occur in patients who do not respond to first-line TB treatments. These symptoms include:
– Persistent cough that lasts three weeks or longer
– Coughing up blood or sputum
– Chest pain, or pain with breathing or coughing
– Unintentional weight loss
– Fatigue
– Fever
– Night sweats
– Chills
– Loss of appetite
Patients who exhibit these symptoms and have a history of TB treatment or have been in contact with drug-resistant TB cases are prime candidates for this test.
The Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test is a crucial tool in the fight against TB. It allows healthcare providers to quickly identify drug-resistant strains of TB and adjust treatment plans accordingly. This rapid identification is vital for preventing the spread of resistant strains and ensuring patients receive the most effective treatment possible.
For more information on this test, including how to order it, please visit [DNA Labs UAE](https://dnalabsuae.com/tests/cultured-afb-antitubercular-dst-rapid-10-second-line-drugs-panel-test/).
—
Symptoms of Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test
Tuberculosis (TB) remains a significant global health challenge, with millions of new cases diagnosed each year. The disease, caused by the bacterium Mycobacterium tuberculosis, primarily affects the lungs but can also impact other parts of the body. Early detection and appropriate treatment are crucial for managing TB effectively. In this context, the Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test represents a significant advancement in the diagnosis and management of drug-resistant forms of tuberculosis. Offered by DNA Labs UAE, this test is specifically designed to detect resistance to second-line antitubercular drugs, providing essential information for tailoring treatment plans.
The test costs 2460 AED and can be further explored by visiting DNA Labs UAE’s website.
The symptoms that might prompt a physician to recommend the Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test are varied. They often resemble those of standard tuberculosis but occur in patients who do not respond to first-line TB treatments. These symptoms include:
- Persistent cough that lasts three weeks or longer
- Coughing up blood or sputum
- Chest pain, or pain with breathing or coughing
- Unintentional weight loss
- Fatigue
- Fever
- Night sweats
- Chills
- Loss of appetite
Patients who exhibit these symptoms and have a history of TB treatment or have been in contact with drug-resistant TB cases are prime candidates for this test.
The Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test is a crucial tool in the fight against TB. It allows healthcare providers to quickly identify drug-resistant strains of TB and adjust treatment plans accordingly. This rapid identification is vital for preventing the spread of resistant strains and ensuring patients receive the most effective treatment possible.
For more information on this test, including how to order it, please visit DNA Labs UAE.
“`
